pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection

Vaccine

Volumn 26, Issue 3, 2008, Pages 305-315

  Malheiro, Adriana ^a   Aníbal, Fernanda F ^a   Martins Filho, Olindo Assis ^b   Teixeira Carvalho, Andréa ^b   Perini, Adenir ^a   Martins, Milton A ^a   Medeiros, Alexandra I ^a   Turato, Walter M ^a   Acencio, Milene P M ^a   Brandão, Izaíra T ^a   Nomizo, Auro ^a   Silva, Célio L ^a   Faccioli, Lúcia H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Airway hyperresponsiveness; DNA vaccine; Eosinophilic inflammation; pcDNA IL 12; Toxocariasis

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PCDNA3 CPG VACCINE; PCDNA3 INTERLEUKIN 12 VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; EOSINOPHIL; FEMALE; GENE GUN IMMUNIZATION; IMMUNE RESPONSE; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TOXOCARA CANIS; TOXOCARIASIS; TREATMENT RESPONSE;

ANIMALS; BIOLISTICS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CPG ISLANDS; DOGS; FEMALE; INTERLEUKIN-12; LUNG; MICE; MICE, INBRED BALB C; PLASMIDS; PULMONARY EOSINOPHILIA; TOXOCARA CANIS; TOXOCARIASIS; TREATMENT OUTCOME; VACCINATION; VACCINES, DNA;

EID: 37549042030     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.023     Document Type: Article

References (35)

1. Nutman T.B., Ottesen E.A., and Cohen S.G. The eosinophil, eosinophilia, and eosinophil-related disorders. Allergy Proc 10 (1989) 47-62
2. Beaver P., Snyder H., Carrera G., Dent J., and Lafferty J. Chronic eosinophilia due to visceral larva migrans. Pediatrics 9 (1952) 7-19
3. Anibal F.F., Rogerio A.P., Malheiro A., Machado E.R., Martins-Filho O.A., Andrade M.C., et al. Impact of MK886 on eosinophil counts and phenotypic features in toxocariasis. Scand J Immunol 65 (2007) 344-352
4. Walsh G.M. Targeting airway inflammation: novel therapies for the treatment of asthma. Curr Med Chem 13 (2006) 3105-3111
5. Azzawi M., Bradley B., Jeffery P.K., Frew A.J., Wardlaw A.J., Knowles G., et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsy in stable atopic asthma. Am Rev Respir Dis 142 (1990) 1407-1413
6. Bousquet J., Chanez P., Lacoste J.Y., Barnéon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. New Engl J Med 323 (1990) 1033-1039
7. Mosmann T.R., and Sad S. The expanding universe of T cell subsets Th1, Th2 and more. Immunol Today 17 (1996) 138-146
8. Steel C., and Nutman T.B. Regulation of IL-5 in onchocerciasis. A critical role for IL-2. J Immunol 150 (1993) 5511-5518
9. Faccioli L.H., Mokwa V.F., Silva C.L., Rocha G.M., Araujo J.I., Nahori M.A., et al. IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome. Med Inflamm 5 (1996) 24-31
10. Yamaguchi Y., Matsui T., Kasahara T., Etoh S., Tominaga A., Takatsu K., et al. In vivo changes of hemopoietic progenitors and the expression of the interleukin 5 gene in eosinophilic mice infected with Toxocara canis. Exp Hematol 18 (1990) 1152-1157
11. Kuribayashi K., Kodama T., Okamura H., Sugita M., and Matsuyama T. Effects of post-inhalation treatment with interleukin-12 on airway hyper-reactivity, eosinophilia and interleukin-18 receptor expression in a mouse model of asthma. Clin Exp Allergy 32 (2002) 641-649
12. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., et al. Natural killer cell stimulatory factor (Interleukin 12[IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 177 (1993) 1199-1204
13. + T lymphocytes. J Immunol 155 (1995) 111-117
14. Won Han S., Moraes J.Z., Silva C.L., Chammas R., and Rodrigues M.M. DNA vaccine. In: Yury E., Khudyakov, Howard A., and Fields (Eds). Artificial DNA, methods and applications (2003), CRC Press, Florida 329-361
15. Van Uden J., and Raz E. Immunostimulatory DNA and applications to allergic disease. J Allergy Clin Immunol 104 (1999) 902-910
16. Stampfli M.R., Scott Neigh G., Wiley R.E., Cwiartka M., Ritz S.A., Hitt M.M., et al. Regulation of allergic mucosal sensitization by interleukin-12 gene transfer to airway. Am J Respir Cell Mol Biol 21 (1999) 317-325
17. Lowrie D.B., Tascon R.E., Bonato V.L., Lima V.M., Faccioli L.H., Stavropoulos E., et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 400 (1999) 269-271
18. Schultz J., Heinzerling L., Pavlovic J., and Moelling K. Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA. Cancer Gene Ther 7 (2000) 1557-1565
19. Lima K.M., Santos A.S., Santos RRJr, Brandão I.T., Rodrigues JMJr, and Silva C.L. Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo. Vaccine 8 (2003) 49-56
20. Li H.Q., Shao C.S., and Xie Q.M. The effect of a mouse IL-12 plasmid on airway inflammation and cytokine production in a mouse asthmatic model. Zhonghua Jie He He Hu Xi Za Zhi 26 (2003) 354-357
21. Weiss R., Hammerl P., Hartl A., Hochreiter R., Leitner W.W., Scheiblhofer S., et al. Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases. Curr Drug Targets Inflamm Allergy 4 (2005) 585-597
22. Taube C., Nick J.A., Siegmund B., Duez C., Takeda K., Rha Y.H., et al. Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 30 (2004) 837-843
23. Sur S., Bouchard P., Holbert D., and Van Scott M.R. Mucosal IL-12 inhibits airway reactivity to methacholine and respiratory failure in murine asthma. Exp Lung Res 26 (2000) 477-489
24. Bryan S.A., O'Connor B.J., Matti S., Leckie M.J., Kanabar V., Khan J., et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 (2000) 2149-2153
25. Lee Y.L., Ye Y.L., Yu C.I., Wu Y.L., Lai Y.L., Ku P.H., et al. Construction of single-chair interleukin-12 DNA plasmid to treat airway, hyperresponsiveness in an animal model of asthma. Hum Gene Ther 12 (2001) 2065-2079
26. Bruselle G.G., Kips J.C., Peleman R.A., Joos G.F., Devos R.R., Tavernier J.H., et al. Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12. Am J Respir Cell Mol Biol 17 (1997) 767-771
27. Williman J., Lockhart E., Slobbe L., Buchan G., and Baird M. The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun. Vaccine 24 (2006) 4471-4474
28. Negrão-Correa D., Silveira M.R., Borges C.M., Souza D.G., and Teixeira M.M. Changes in pulmonary function and parasite burden in rats infected with Strongyloides venezuelensis concomitant with induction of allergic airway inflammation. Infect Immun 71 (2003) 2607-2614
29. Wilder J.A., Collie D.D., Wilson B.S., Bice D.E., Lyons C.R., and Lipscomb M.F. Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am J Respir Cell Mol Biol 20 (1999) 1326-1334
30. Leckie M.J., Ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356 (2000) 2144-2148
31. Park S.T., Kim K.E., Na K., Kim Y., and Kim T.Y. Effect of dendritic cells treated with CpG ODN on atopic dermatitis of Nc/Nga mice. J Biochem Mol Biol 40 4 (2007) 486-493
32. Zhang Y., Shoda L.K., Brayton K.A., Estes D.M., Palmer G.H., and Brown W.C. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. J Interferon Cytokine Res 21 10 (2001) 871-881
33. Zhang Y., Palmer G.H., Abbott J.R., Howard C.J., Hope J.C., and Brown W.C. CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum. Vaccine 21 23 (2003) 3307-3318
34. Choi J.H., Ko H.M., Park S.J., Kim K.J., Kim S.H., and Im S.Y. CpG oligodeoxynucleotides protect mice from lethal challenge with Candida albicans via a pathway involving tumor necrosis factor-alpha-dependent interleukin-12 induction. FEMS Immunol Med Microbiol 51 1 (2007) 155-162
35. Bullens D.M. Measuring T cell cytokines in allergic upper and lower airway inflammation: can we move to the clinic?. Inflamm Allergy Drug Targets 6 2 (2007) 81-90